Syngene International ropes in Yogesh Pandey as Talent Acquisition Lead

Published On 2025-04-25 09:53 GMT   |   Update On 2025-04-25 09:53 GMT
Advertisement

KarnatakaSyngene International Limited has appointed Yogesh Pandey as Talent Acquisition Lead in the Company.

In a recent LinkedIn post, Yogesh stated, "Excited to announce my new role as Talent Acquisition Lead at Syngene International Limited! With a key emphasis on attracting early career professionals to the company."
"It's a thrilling opportunity to cultivate and develop scientific talent, contributing to the dynamic #CRO & #CDMO Industry where Syngene International Limited maintains its pioneering position," he added.

Yogesh is a professional with 25 years of experience in Recruitment Delivery, Design, Talent Analytics, Change management, and Recruitment Process Outsourcing (RPO) in the India and APAC Region

Prior to joining Syngene, he worked at various organisations including Fidelity International, Wolters Kluwer, Barclays, IBM India, Quatrro BPO Solutions Pvt Ltd, Bank of America Continuum, 
ABC Consultants, Eicher.

In addition to his professional accomplishments, he is also the author of a Published case study in Ivey Publication on organizations adopting analytics at the workplace to manage remote workers' performance.

He is also an Avid Reader and Half Marathon runner, he shared in his LinkedIn bio.

Read also: Syngene biologics manufacturing facility to be operational for US, European customers from mid year

Syngene International has also announced the resignation of Priyadarshini Mahapatra from her role as Head Legal, Company Secretary & Compliance Officer; and Key Managerial Personnel of the Company to pursue other career opportunities.

Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. With 2.2 Mn sq. ft of specialized discovery, development, and manufacturing facilities, Syngene works with biotech companies pursuing leading-edge science as well as multinationals, including BMS, GSK, Zoetis and Merck KGaA.

Read also: Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News